Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
$5.40
-0.7%
$3.95
$1.92
$6.02
$192.72M0.69969,170 shs111,266 shs
Positron Corp. stock logo
POSC
Positron
$1.64
-1.3%
$1.59
$0.92
$2.94
$51.47M0.4329,827 shs2,460 shs
Pheton Holdings Ltd stock logo
PTHL
Pheton
$0.85
-4.8%
$15.44
$0.60
$32.00
$5.59MN/A4.32 million shs544,710 shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$2.50
+14.2%
$2.25
$1.54
$2.72
$215M1.51697,203 shs1.12 million shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
0.00%+0.19%+63.14%+100.74%+137.89%
Positron Corp. stock logo
POSC
Positron
0.00%-6.18%+10.74%+12.26%+47.66%
Pheton Holdings Ltd stock logo
PTHL
Pheton
0.00%+4.94%-95.84%-80.64%+84,999,900.00%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.00%+12.61%+11.61%+17.37%+38.89%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
1.691 of 5 stars
1.85.00.00.02.21.70.6
Positron Corp. stock logo
POSC
Positron
0.3491 of 5 stars
0.03.00.00.01.90.80.0
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.1981 of 5 stars
0.00.00.00.01.91.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.40N/A
Positron Corp. stock logo
POSC
Positron
0.00
N/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
0.00
N/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
$370K520.88N/AN/A$0.42 per share12.86
Positron Corp. stock logo
POSC
Positron
$590K87.24N/AN/A($0.04) per share-40.98
Pheton Holdings Ltd stock logo
PTHL
Pheton
$450K12.43N/AN/A$0.94 per share0.90
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$26.92M7.99N/AN/A$0.07 per share35.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$16.33M-$0.45N/AN/AN/AN/A-115.71%-92.75%8/13/2025 (Estimated)
Positron Corp. stock logo
POSC
Positron
-$2.39M-$0.12N/AN/A-592.35%N/A-116.31%N/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
-$660KN/A0.00N/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$24.05M-$0.28N/AN/AN/A-73.43%-354.30%-48.87%N/A

Latest POSC, MGRM, STXS, and PTHL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.11N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Positron Corp. stock logo
POSC
Positron
N/A-$0.05N/A-$0.05N/A$0.12 million
5/14/2025Q1 2025
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.12-$0.10+$0.02-$0.10N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
Positron Corp. stock logo
POSC
Positron
N/AN/AN/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.00
7.00
Positron Corp. stock logo
POSC
Positron
N/A
2.69
2.04
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
12.39
12.17
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/A
1.07
0.66

Institutional Ownership

CompanyInstitutional Ownership
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%
Positron Corp. stock logo
POSC
Positron
N/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
45.35%

Insider Ownership

CompanyInsider Ownership
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
Positron Corp. stock logo
POSC
Positron
17.20%
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
17.77%
CompanyEmployeesShares OutstandingFree FloatOptionable
Monogram Orthopaedics Inc. stock logo
MGRM
Monogram Orthopaedics
2835.69 million25.66 millionNot Optionable
Positron Corp. stock logo
POSC
Positron
2031.41 million26.00 millionNot Optionable
Pheton Holdings Ltd stock logo
PTHL
Pheton
116.58 millionN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
13086.00 million70.72 millionNot Optionable

Recent News About These Companies

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript
Stereotaxis Reports 2025 Second Quarter Financial Results
Stereotaxis (STXS) to Release Earnings on Thursday
Stereotaxis (STXS) Gets a Buy from TD Cowen
Stereotaxis Wins FDA Nod for Catheter
Stereotaxis announces $12.5M offering
Stereotaxis Sinks on Common Stock Offering
Stereotaxis, Inc. (STXS) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$5.40 -0.04 (-0.74%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$5.44 +0.03 (+0.65%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Positron stock logo

Positron OTCMKTS:POSC

$1.64 -0.02 (-1.27%)
As of 08/8/2025 01:39 PM Eastern

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Pheton stock logo

Pheton NASDAQ:PTHL

$0.85 -0.04 (-4.75%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$0.86 +0.01 (+1.53%)
As of 08/8/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

Stereotaxis stock logo

Stereotaxis NYSEAMERICAN:STXS

$2.50 +0.31 (+14.16%)
Closing price 08/8/2025 04:10 PM Eastern
Extended Trading
$2.49 -0.01 (-0.40%)
As of 08/8/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.